Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Celecoxib in Preventing Skin Cancer
This study has been withdrawn prior to recruitment.
Study NCT00025051 Information provided by National Cancer Institute (NCI)
First Received: October 11, 2001 Last Updated: January 11, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Non-Melanomatous Skin Cancer
Additional conditions recognized in this trial
Skin Neoplasms
More general conditions related to this trial
Neoplasms
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
celecoxib
anti-cytokine therapy
antiangiogenesis therapy
biological therapy
cancer prevention intervention
chemoprevention of cancer
growth factor antagonist therapy
Additional drug interventions recognized in this trial
Mitogens
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Herbert Irving Comprehensive Cancer Center
National Cancer Institute (NCI)
Back to top of Main Content
